The present report is concerned with the events in Spain surrounding two cases of infection with Crimean-Congo Haemorrhagic Fever (CCHF) virus that emerged in the Autonomous Community of Castilla y León in August 2016.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 July 2018 and includes updates on carbapenemase-producing (OXA-48) Klebsiella pneumoniae, dengue, Ebola virus disease, poliomyelitis, MERS-CoV, mass gathering monitoring (FIFA Men's Football World Cup), measles, poliovirus type 2, rubella, Vibrio growth in the Baltic Sea, and West Nile virus.
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
In Europe, about 80 000 hospitalised patients are estimated to have at least one healthcare-associated infection on any given day. Proper cleaning of the hands, using antiseptic fluid, remains the single most effective way for hospital staff to prevent infections that can lead to sepsis.
This report is based on data for 2016 retrieved from The European Surveillance System (TESSy) on 26 April 2018. TESSy is a system for the collection, analysis and dissemination of data on communicable diseases. EU Member States and EEA countries contribute to the system by uploading their infectious disease surveillance data at regular intervals.
This report provides a comprehensive update of the epidemiology of pneumonia, bloodstream infections and urinary tract infections European ICUs as well as important reference data for European ICUs performing surveillance of ICU-acquired infections.
Following the occurrence of several hospital-acquired malaria cases in the European Union (EU), ECDC has assessed the risk related to transmission of the parasite in hospital settings.
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries